Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome

被引：1
|
作者：
Yun, Karen M. [1 ]
Narezkina, Anna [2 ,3 ]
Redfern, Charles [4 ]
Velasco, Katherine [1 ]
Bazhenova, Lyudmila [1 ]
机构：
[1] UC San Diego Hlth, Moores Canc Ctr, Div Hematol Oncol, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA
[2] Univ Calif Med Ctr, Div Cardiol, La Jolla, CA USA
[3] Sulpizio Cardiovasc Ctr, La Jolla, CA USA
[4] Sharp HealthCare, Med Oncol, San Diego, CA USA
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
SOLID TUMORS; LAROTRECTINIB;
D O I：
10.1200/PO.23.00265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
    Marczyk, Vicente R.
    Fazeli, Sasan
    Dadu, Ramona
    Busaidy, Naifa L.
    Iyer, Priyanka
    Hu, Mimi I.
    Sherman, Steven I.
    Hamidi, Sarah
    Hosseini, Sayed Mohsen
    Williams, Michelle D.
    Ahmed, Salmaan
    Routbort, Mark J.
    Luthra, Raja
    Roy-Chowdhuri, Sinchita
    San Lucas, Francis Anthony
    Patel, Keyur P.
    Hong, David S.
    Zafereo, Mark
    Wang, Jennifer R.
    Maniakas, Anastasios
    Waguespack, Steven G.
    Cabanillas, Maria E.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [2] NTRK Fusion-Positive Congenital Spinal Glioblastoma treated with Carboplatin, Etoposide, and Larotrectinib
    Vallis, Graham
    PEDIATRICS, 2021, 147 (03)
  • [3] Challenges in the Diagnosis of NTRK Fusion-Positive Cancers
    Gautschi, Oliver
    Bubendorf, Lukas
    Leyvraz, Serge
    Menon, Roopika
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E107 - E109
  • [4] Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours
    Lassen, Ulrik
    LANCET ONCOLOGY, 2020, 21 (02): : 193 - 194
  • [5] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 817 - 818
  • [6] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 817 - 818
  • [7] Challenges in the Diagnosis of NTRK Fusion-Positive Cancers Response
    Jett, James R.
    Kim, Edward S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E109 - E110
  • [8] NTRK fusion-positive cancers and TRK inhibitor therapy
    Cocco, Emiliano
    Scaltriti, Maurizio
    Drilon, Alexander
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 731 - 747
  • [9] NTRK fusion-positive colorectal cancer in Japanese population
    Yonemaru, Junpei
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Naka, Tomoaki
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Shiraishi, Kouya
    Sekine, Shigeki
    PATHOLOGY INTERNATIONAL, 2021, 71 (05) : 355 - 359
  • [10] NTRK fusion-positive cancers and TRK inhibitor therapy
    Emiliano Cocco
    Maurizio Scaltriti
    Alexander Drilon
    Nature Reviews Clinical Oncology, 2018, 15 : 731 - 747
12345